Re-examining the Poison Pill

Re-examining the Poison Pill

click to enlarge
Frank Voisin is a value investor and independent analyst whose site, Frankly Speaking, contains Frank’s investment theses as well as educational material to help investors avoid value traps. Subscribe to Frank’s feed here.

The poison pill, also known as a shareholder rights plan, is a defensive tactic used by companies to defend against hostile takeovers. The poison pill allows current shareholders to buy more shares at a massive discount, which would increase the cost of an acquisition. This forces bidders to negotiate with the company’s board of directors, rather than going directly to shareholders. For value investors, it is important to consider the presence of poison pills, because a potential catalyst – an acquisition of the undervalued company – is eliminated.

Greenhaven Road Capital 3Q22 Commentary

chart 1663692248Greenhaven Road Capital commentary for the third quarter ended September 30, 2022. Q3 2022 hedge fund letters, conferences and more Dear Fellow Investors, The Fund is enduring its worst drawdown since inception. We were down again in the third quarter, bringing year -to-date returns to approximately -59%. Returns vary by . . . SORRY! This Read More

The question is again, who decides? A board has the responsibility of running a company. But the shareholders are the ultimate owners of the company. In the J. C. Penney case, the poison pill is chilling discussions about the company’s future. In the Airgas case, the poison pill is being used to prevent shareholders from deciding themselves.

NYTimes’ Dealbook published a great article about several recent court cases involving poison pills and the future judicial interpretation of how poison pills may be used. It is an interesting read and you can check out the full article here.

No posts to display